Search
Sign Up
Home
Team
Pipeline
Back
Sr89/Metastron
QBM-001
Uttroside-B
MAN-01
Investors
Back
Presentations
Stock Info
Filings
Media
News
Back
News 2025
News 2024
News 2023
News 2022
News 2021
News 2020
News 2019
News 2018
News 2017
News 2016
Contact
Video & Social Media
Watch us in interviews. Follow us.
2019 News
List of articles in category 2019 News
Title
Created Date
Q BioMed Technology Partner Mannin Research Inc. Presents Data Showing Potential Treatment to Protect the Kidney in Acute Kidney Injury Using Mannin Tie2 Activator
Nov 26, 2019
Q BioMed Announces FDA Approval
Nov 20, 2019
Q BioMed Announces $7.5M Grant Benefiting its Preclinical Product Development Pipeline
Nov 05, 2019
Q BioMed Announces Commercial Partnership with Jubilant Radiopharma for the Distribution of its Non-Opioid Cancer Palliation Drug in the United States
Oct 03, 2019
Q BioMed Announces Legal Settlement and Acquisition of FDA approved Non-Opioid Metastatic Cancer Pain Drug
Oct 02, 2019
Q BioMed and Collaborator Chemveda Life Sciences Enter Agreement for Synthesis and Manufacturing of Liver Cancer Chemotherapeutic
Sep 11, 2019
Q Biomed And Collaborator Chemveda Life Sciences Announce Potential Chemotherapeutic Breakthrough In Liver Cancer
Aug 20, 2019
Q BioMed Announces Updates on Commercialization of Non-Opioid Metastatic Cancer Pain Drug
Jul 11, 2019
Q BioMed Files for Orphan Drug Designation with U.S. FDA for Autism Spectrum Disorder Subtype
Jun 28, 2019
Q BioMed Responds to OTC Markets Request for Clarity on Promotional Activity
Jun 24, 2019
Q BioMed Advances QBM-001 for the Treatment of Autism Spectrum Disorder Subtype
Jun 04, 2019
Biotechnology Accelerator, Q BioMed Inc., Selects 5W Public Relations as Agency of Record
May 30, 2019
Q BioMed Research Partner Mannin Research to Attend ARVO 2019 Annual Meeting
Apr 24, 2019
In a Major Breakthrough, Q BioMed Discovers First Biomarkers for Pediatric Nonverbal Autism Subgroup
Apr 10, 2019
Q BioMed and Mannin Research to Develop GDF15 Biomarker Glaucoma Diagnostic Kit Through Collaboration with McMaster University
Mar 19, 2019
Q BioMed Licenses Novel Biomarker for Monitoring Glaucoma Severity and Progression from Washington University
Mar 11, 2019
Q BioMed's Autism Spectrum Disorder Drug Development Program Featured in February Issue of Leading Pharma/Biotech Newspaper
Feb 26, 2019
Interviews with CEO Denis Corin of Q BioMed and CEO George Nikopoulos of Mannin Research
Feb 23, 2019
Q BioMed Responds to OTC Markets Request for Clarity on Investor Awareness Activity
Feb 07, 2019
FinancialBuzz.com Exclusive Interview With Chairman and CEO Denis Corin of Q BioMed Inc. Live From Times Square in New York City
Feb 05, 2019
Q BioMed to Present at 2019 BIO CEO & Investor Conference
Feb 01, 2019
Q Biomed Technology Partner Mannin Research Enters Into Collaboration With Mcmaster University For Glaucoma Drug Candidate MAN-01
Jan 25, 2019
Q BioMed Adds Clinical Psychologist at Yale’s Child Study Center, Dr. Pamela Ventola to Advisory Committee for QBM-001
Jan 16, 2019
Update and Outlook in a New Audio Interview
Jan 15, 2019
Q BioMed Inc Provides Shareholder Update
Jan 08, 2019